Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings
This quasi-experimental study investigated the effect of an antibiotic cycling policy based on time-series analysis of epidemiologic data, which identified antimicrobial drugs and time periods for restriction. Cyclical restrictions of amoxicillin/clavulanic acid, piperacillin/tazobactam, and clarith...
Main Authors: | Geraldine Mary Conlon-Bingham, Mamoon Aldeyab, Michael Scott, Mary Patricia Kearney, David Farren, Fiona Gilmore, James McElnay |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2019-01-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/25/1/18-0111_article |
Similar Items
-
National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
by: Kristina Rizzardi, et al.
Published: (2018-09-01) -
Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
by: Teena Chopra, et al.
Published: (2023-01-01) -
Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
by: Kullar R, et al.
Published: (2020-10-01) -
Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing <i>Clostridioides difficile</i> Infection
by: Khalid Alyahya, et al.
Published: (2023-06-01) -
Prevalence, antibiogram, phenotypic and genotypic analysis of Clostridioides difficile toxigenic strains from stool samples
by: Mohammed A. Alqasem, et al.
Published: (2023-08-01)